Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/25/2007WO2007118653A2 Nanoparticle containing nicotine and/or cotinine, dispersions and use thereof
10/25/2007WO2007118363A1 A chinese medicine composition and preparation method and use thereof
10/25/2007WO2007118294A1 Homeopathic composition and kit therefore
10/25/2007WO2007099329A3 Nebulizer formulation
10/25/2007WO2007098591A3 Topical nail formulation
10/25/2007WO2007096902A3 Solid oral dosage forms of griseofulvin
10/25/2007WO2007093808A3 Virucidal materials
10/25/2007WO2007088066A3 Nanoparticles designed for drug delivery
10/25/2007WO2007072061A3 Crystalline pyrimidine nucleoside derivatives suspensions in capsules
10/25/2007WO2007070843A3 Processes for making particle-based pharmaceutical formulations for oral administration
10/25/2007WO2007067593A3 Self-emulsifyng formulations of cetp inhibitors
10/25/2007WO2007064912A3 Mometasone compositions and methods of making and using the same
10/25/2007WO2007063300A3 Particles
10/25/2007WO2007061843A3 Remotely rf powered comformable thermal applicators
10/25/2007WO2007059422A3 Pharmaceutical formulations containing 5-cyclopropyl-2(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and method of making same
10/25/2007WO2007056205A3 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
10/25/2007WO2007056133A3 Herbal composition for weight management
10/25/2007WO2007051774A3 Process for the preparation of sterile powdered pharmaceutical compounds
10/25/2007WO2007047922A3 Polymer-drug conjugates
10/25/2007WO2007035942A3 Transdermal risperidone delivery system
10/25/2007WO2007033281A3 Ion exchange resin treated to control swelling
10/25/2007WO2007011940A3 Sustained release of antiinfectives
10/25/2007WO2007009730B1 Polymer film for transdermal patches containing a pharmaceutical active agent
10/25/2007WO2007002540A3 Radiolabeled-pegylation of ligands for use as imaging agents
10/25/2007WO2006138735A3 Gel compositions for topical administration
10/25/2007WO2006127282A3 Center-filled chewing gum composition
10/25/2007WO2006119355A3 Mammalian hypothalamic nutrient modulation of glucose metabolism
10/25/2007WO2006096161A8 Methods and compositions for modified release of nutritional supplements
10/25/2007WO2006084696A9 Production of dosage forms comprising a solid dispersion of a microcrystalline agent
10/25/2007WO2005084326A3 Multilayered nanomedicine delivery system and method
10/25/2007WO2002017853A3 Hyaluronan-based antiadhesion compositions, their preparation and use
10/25/2007US20070250046 Controlled release devices for therapeutic treatments of spinal discs
10/25/2007US20070249734 Method, Composition and Kit for Detecting Phosphatidylserine (Ps) on Cell Membranes
10/25/2007US20070249692 Inhibitors of crystallization in a solid dispersion
10/25/2007US20070249673 Method for administering tolperisone
10/25/2007US20070249671 Pharmaceutical composition for piperidinoalkanol compounds
10/25/2007US20070249656 administering by inhalation or nasal route a suspension of crystalline tiotropium bromide monohydrate in propellant gases HFA 227 and/or HFA 134a, optionally in admixture with other propellant gases chosen from propane, butane, pentane, dimethylether, CHClF2, CH2F2, CF3CH3, isobutane etc.; asthma; COPD
10/25/2007US20070249643 Solid pharmaceutical dosage form
10/25/2007US20070249576 Cefdinir Oral Suspension
10/25/2007US20070249570 Homogeneously formulating microdosed active principles
10/25/2007US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides
10/25/2007US20070249522 Injectable formulations containing succinate
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248724 Method and device for sanitation using bacteriophages
10/25/2007US20070248702 Use of CB2 receptors agonists for the treatment of Huntington's disease
10/25/2007US20070248698 Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic Activity
10/25/2007US20070248697 Opthalmic solutions
10/25/2007US20070248686 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
10/25/2007US20070248685 crosslinking gelatin with glutaraldehyde crosslinker in the presence of certain re-hydration aids, such as polyethylene glycol, polyvinylprovidone, and dextran; useful for providing hemostasis at surgical bleeding sites and traumatic bleeding site
10/25/2007US20070248684 Pharmaceutical formulations of oxcarbazepine and methods for its preparation
10/25/2007US20070248683 Novel Compositions of Fat-Soluble Substances
10/25/2007US20070248682 Solid preparation comprising enteric solid dispersion
10/25/2007US20070248681 Solid dispersion preparation
10/25/2007US20070248680 Particles for Inactivating Toxins
10/25/2007US20070248679 Vaccine
10/25/2007US20070248678 Uniform-sized hydrophilic metal oxide nanoparticles and preparation method thereof
10/25/2007US20070248677 Method for treating warm-blooded vertebrates with a salt of a halide-free glucosamine base and a therapeutic drug
10/25/2007US20070248676 Use of nitric oxide adducts
10/25/2007US20070248675 Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
10/25/2007US20070248674 Hydrogel Interferon Formulations
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007US20070248671 Asymmetric membranes for drug delivery devices
10/25/2007US20070248670 Tolterodine beads
10/25/2007US20070248669 Oral sustained release formulation
10/25/2007US20070248667 Tannate Compositions and Methods of Use
10/25/2007US20070248666 Granules Comprising a Beta-Lactam Antibiotic
10/25/2007US20070248665 Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
10/25/2007US20070248664 Oral Antimicrobial Pharmaceutical Compositions
10/25/2007US20070248663 Utilization of Dialkylfumerates
10/25/2007US20070248662 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
10/25/2007US20070248661 Capsule for Releasing Agents Contained Therein at Defined Points In a Body
10/25/2007US20070248660 Such as polyoxyethylene, polyacrylamide homopolymers/copolymers with adrenergic agonists, narcotic and non-narcotic analgesics
10/25/2007US20070248659 Individualized cancer therapy
10/25/2007US20070248658 Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
10/25/2007US20070248657 Multi-compartment transdermal pain control device
10/25/2007US20070248652 Nutritional Food and Feed, Compostition, Processing and Method of Use
10/25/2007US20070248651 Formulation for treatment of acne
10/25/2007US20070248646 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
10/25/2007US20070248645 Ophthalmic Oil-in-Water Type Emulsion with Stable Positive Zeta Potential
10/25/2007US20070248644 Muller Stem Cells
10/25/2007US20070248643 Polymerizable emulsions for tissue engineering
10/25/2007US20070248642 Foam and use thereof
10/25/2007US20070248641 Use of Del-1 in Hair, Bone and Cartilage Regeneration
10/25/2007US20070248634 Delivery system for an oral care substance
10/25/2007US20070248630 Pharmaceutical formulations for iontophoretic methotrexate delivery
10/25/2007US20070248629 Pharmaceutical formulations for iontophoretic drug delivery
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007US20070248571 Ejection Liquid, Ejection Method, Method for Forming Liquid Droplets, Liquid Ejection Cartridge and Ejection Apparatus
10/25/2007US20070248569 Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
10/25/2007US20070248565 Pharmaceutical preparations comprising corticosteroids and antiinfective agents
10/25/2007US20070248548 Stable hydroalcoholic oral spray formulations and methods
10/25/2007US20070248541 Liposome
10/25/2007US20070245591 Methods for drying objects using aerosols
10/25/2007CA2839228A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
10/25/2007CA2652826A1 A composition comprising extracts of radix ginseng, folium ginkgo, stigma croci and glycine max and use thereof for treating ischemic cerebrovascular disease
10/25/2007CA2650998A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
10/25/2007CA2649207A1 Magnetic nanoparticles compositions and uses thereof
10/25/2007CA2649149A1 Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof
10/25/2007CA2648982A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants
10/25/2007CA2648950A1 Composition including at least one aqueous phase and at least one fatty phase including ivermectin
1 ... 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 ... 2991